Citation Information :
Singh N, Acharya N, Acharya S. Homocysteinemia: A Rare Cause of Recurrent Pregnancy Loss Coexisting with Deep Vein Thrombosis. J South Asian Feder Obs Gynae 2020; 12 (5):328-330.
Deep vein thrombosis (DVT) and venous thromboembolism are major health problems and are leading causes of maternal morbidity and mortality. Recurrent pregnancy loss either early or late is a serious problem and has both psychological and physical impacts. Thrombophilia is one of the most important causes of DVT as well as recurrent pregnancy loss as it worsens the physiological hypercoagulable case which exists in pregnancy. Homocysteinemia is rare but an important cause of DVT and recurrent pregnancy loss. Serum homocysteine levels in pregnancy have been linked to preeclampsia, recurrent abortions, and low birth weight. Diagnosis of this condition is missed on a routine basis due to extremely less frequency of the evaluation of serum homocysteine levels. Here, we report a case of hyperhomocysteinemia as an underlying cause of bad obstetric history and DVT which are a few of the classic presentations of the entity seen in the single patient. The condition was diagnosed by a multidisciplinary approach.
Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management (2) Internet]. (2) cited 2020 Apr 18]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778511/.
Devis P, Knuttinen MG. Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management. Cardiovasc Diagn Ther 2017;7(Suppl 3):S309–S319. DOI: 10.21037/cdt.2017.10.08.
Kupferminc MJ. Thrombophilia and pregnancy. Reprod Biol Endocrinol RBE 2003;1(1):111. DOI: 10.1186/1477-7827-1-111.
Sztenc S. Hyperhomocysteinemia and pregnancy complications. Ginekol Pol 2004;75(4):317–325.
Stoįkova V, Ivanov S, Mazneįkova V, et al. Serum homocysteine levels in pregnant women with preeclampsia. Akush Ginekol (Sofiia) 2005;44(6):16–19.
Del Bianco A, Maruotti G, Fulgieri AM, et al. Recurrent spontaneous miscarriages and hyperhomocysteinemia. Minerva Ginecol 2004;56(5):379–383.
Gris J-C, Perneger TV, Quéré I, et al. Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study. Blood 2003;102(10):3504–3513. DOI: 10.1182/blood-2003-01-0320.
Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta 1999;20(7):519–529. DOI: 10.1053/plac.1999.0417.
Hyperhomocyst(e)inemia and the Increased Risk of Venous Thromboembolism: More Evidence From a Case-Control Study | Venous Thromboembolism | JAMA Internal Medicine | JAMA Network (2) Internet]. (2) cited 2020 May 28]. Available from: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/415732.
Quéré I, Mercier E, Bellet H, et al. Vitamin supplementation and pregnancy outcome in women with recurrent early pregnancy loss and hyperhomocysteinemia. Fertil Steril 2001;75(4):823–825. DOI: 10.1016/S0015-0282(01)01678-8.
Katre P, Bhat D, Lubree H, et al. Vitamin B12 and folic acid supplementation and plasma total homocysteine concentrations in pregnant Indian women with low B12 and high folate status. Asia Pac J Clin Nutr 2010;19(3):335–343.